farnesol and Candidiasis

farnesol has been researched along with Candidiasis in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (35.29)29.6817
2010's8 (47.06)24.3611
2020's3 (17.65)2.80

Authors

AuthorsStudies
Duan, W; Huang, R; Li, C; Liu, S; Wei, X; Xu, Z1
Chen, C; Cong, L; Han, Z; Li, Y; Mao, J; Mao, S; Shan, M; Xie, Z; Zhu, Z1
Dağ, İ; Gürsu, BY; Yapıcı, M1
Jacobsen, ID; Kurzai, O; Leonhardt, I; Polke, M1
Atkin, AL; Hargarten, JC; Moore, TC; Nickerson, KW; Petro, TM1
Bozó, A; Domán, M; Kardos, G; Kovács, R; Majoros, L; Varga, I1
Abe, S; Abe, Y; Hisajima, T; Iijima, R; Maruyama, N; Oshima, H; Tsunashima, R; Yamada, T; Yamazaki, M1
Jouault, T; Poulain, D; Sarazin, A1
Ruhnke, M; Schulz, B; Weber, K1
Belhumeur, P; Shareck, J1
Ishii, Y; Izumikawa, K; Kimura, S; Kohno, S; Ohno, A; Saga, T; Tashiro, M; Tashiro, T; Tateda, K; Yamaguchi, K1
Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Giffoni Leite, JJ; Lima, DT; Monteiro, AJ; Paiva, MA; Rocha, MF; Sidrim, JJ; Teixeira, CE1
Hornby, JM; Nickerson, KW1
Duhamel, GE; Hoerrmann, N; Hornby, JM; Navarathna, DH; Nickerson, KW; Parkhurst, AM1
Bauer, J; Hellwig, D; Martin, R; Osherov, N; Saluz, HP; Shadkchan, Y; Sickinger, S; Tretiakov, A; Walther, A; Wendland, J1
Duhamel, GE; Hornby, JM; Krishnan, N; Navarathna, DH; Nickerson, KW; Parkhurst, A1
Duhamel, GE; Jerrels, TR; Navarathna, DH; Nickerson, KW; Petro, TM1

Reviews

2 review(s) available for farnesol and Candidiasis

ArticleYear
Farnesol signalling in Candida albicans - more than just communication.
    Critical reviews in microbiology, 2018, Volume: 44, Issue:2

    Topics: Anti-Infective Agents; Candida albicans; Candidiasis; Farnesol; Host-Pathogen Interactions; Humans; Immunologic Factors; Quorum Sensing; Signal Transduction

2018
Modulation of morphogenesis in Candida albicans by various small molecules.
    Eukaryotic cell, 2011, Volume: 10, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Benzoquinones; Candida albicans; Candidiasis; Cell Cycle; Cyclooxygenase Inhibitors; Farnesol; Fatty Acids; Histone Deacetylase Inhibitors; Humans; Lactams, Macrocyclic; Morphogenesis; Sirolimus; Virulence

2011

Other Studies

15 other study(ies) available for farnesol and Candidiasis

ArticleYear
    Biofouling, 2021, Volume: 37, Issue:8

    Topics: Animals; Antifungal Agents; Candidiasis; Candidiasis, Oral; Farnesol; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pharmaceutical Preparations

2021
Inhibitory effects of a maleimide compound on the virulence factors of
    Virulence, 2023, Volume: 14, Issue:1

    Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Farnesol; Humans; Hyphae; Maleimides; Virulence Factors

2023
In vitro antibiofilm efficacy of farnesol against Candida species.
    International microbiology : the official journal of the Spanish Society for Microbiology, 2021, Volume: 24, Issue:2

    Topics: Antifungal Agents; Biofilms; Candida; Candida albicans; Candidiasis; Farnesol; Humans; Microbial Sensitivity Tests

2021
Candida albicans Quorum Sensing Molecules Stimulate Mouse Macrophage Migration.
    Infection and immunity, 2015, Volume: 83, Issue:10

    Topics: Animals; Candida albicans; Candidiasis; Cell Movement; Cells, Cultured; Chemotactic Factors; Farnesol; Female; Humans; Macrophages; Mice; Mice, Inbred C57BL; Quorum Sensing

2015
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Journal of microbiology (Seoul, Korea), 2016, Volume: 54, Issue:11

    Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Farnesol; Female; Fluconazole; Mice; Microbial Sensitivity Tests; Quorum Sensing; Vagina; Virulence; Vulvovaginitis

2016
Suppression of anti-Candida activity of macrophages by a quorum-sensing molecule, farnesol, through induction of oxidative stress.
    Microbiology and immunology, 2009, Volume: 53, Issue:6

    Topics: Animals; Candida albicans; Candidiasis; Cells, Cultured; Farnesol; Humans; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Oxidative Stress; Phagocytosis; Quorum Sensing

2009
In vitro pro- and anti-inflammatory responses to viable Candida albicans yeasts by a murine macrophage cell line.
    Medical mycology, 2010, Volume: 48, Issue:7

    Topics: Animals; Candida albicans; Candidiasis; Cell Line; Coculture Techniques; Farnesol; Glycolipids; Host-Pathogen Interactions; Inflammation; Interleukin-10; Macrophages; Mice; Tumor Necrosis Factor-alpha

2010
The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida species.
    Yeast (Chichester, England), 2010, Volume: 27, Issue:9

    Topics: Biofilms; Candida; Candidiasis; Culture Media; Farnesol; Humans; Quorum Sensing; Serum; Temperature

2010
Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis.
    Medical mycology, 2012, Volume: 50, Issue:4

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Farnesol; Female; Mice; Mice, Inbred C3H; Pravastatin; Survival Analysis; Virulence Factors

2012
Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
    Medical mycology, 2013, Volume: 51, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Farnesol; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests

2013
Enhanced production of farnesol by Candida albicans treated with four azoles.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Antifungal Agents; Azoles; Bridged Bicyclo Compounds, Heterocyclic; Candida albicans; Candidiasis; Farnesol; Gas Chromatography-Mass Spectrometry; Sterols

2004
Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:6

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Farnesol; Fluconazole; Gas Chromatography-Mass Spectrometry; Mice; Microbial Sensitivity Tests; Survival Analysis; Virulence

2005
Use of the Porcine Intestinal Epithelium (PIE)-Assay to analyze early stages of colonization by the human fungal pathogen Candida albicans.
    Journal of basic microbiology, 2006, Volume: 46, Issue:6

    Topics: Amino Acid Transport Systems; Animals; Aspartic Acid Endopeptidases; Candida albicans; Candidiasis; Cell Adhesion; DNA, Fungal; Farnesol; Female; In Vitro Techniques; Intestinal Mucosa; Mice; Microscopy, Fluorescence; Mutagenesis, Insertional; Phosphotransferases (Alcohol Group Acceptor); Survival Analysis; Swine; Virulence

2006
Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
    Infection and immunity, 2007, Volume: 75, Issue:4

    Topics: Animals; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Farnesol; Female; Gene Deletion; Genes, Fungal; Kidney; Mice; Virulence Factors

2007
Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model.
    Infection and immunity, 2007, Volume: 75, Issue:8

    Topics: Animals; Candida albicans; Candidiasis; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Farnesol; Female; Flow Cytometry; Macrophages, Peritoneal; Mice; Virulence Factors

2007